Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Proceedings of the National Academy of Sciences of the United States of America Année : 2021

Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child

Peng Zhang
Isabelle Melki
Lucy Bizien
Flore Rozenberg
Guy Gorochov

Résumé

We describe an unvaccinated child at risk for life-threatening COVID-19 due to an inherited deficiency of IRF9, which governs ISGF-3–dependent responses to type I and III interferons (IFN). She was admitted, with a high nasal SARS-CoV-2 load on day 1 of upper respiratory tract infection. She was viremic on day 2 and received casirivimab and imdevimab. Her clinical manifestations and viremia disappeared on days 3 and 4, respectively. Circulating SARS-CoV-2 virus induced the expression of IFN-stimulated genes in leukocytes on day 1, whereas the secretion of blood type I IFNs, which peaked on day 4, did not. Antibody-mediated SARS-CoV-2 neutralization is, therefore, sufficient to overcome a deficiency of antiviral IFNs.

Domaines

Virologie
Fichier principal
Vignette du fichier
e2114390118.full.pdf (1.06 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03408790 , version 1 (29-10-2021)

Licence

Paternité

Identifiants

Citer

Romain Lévy, Peng Zhang, Paul Bastard, Karim Dorgham, Isabelle Melki, et al.. Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child. Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (45), pp.e2114390118. ⟨10.1073/pnas.2114390118⟩. ⟨hal-03408790⟩
43 Consultations
209 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More